132 related articles for article (PubMed ID: 34147517)
41. Solubility enhancement of desloratadine by solid dispersion in poloxamers.
Kolašinac N; Kachrimanis K; Homšek I; Grujić B; Ðurić Z; Ibrić S
Int J Pharm; 2012 Oct; 436(1-2):161-70. PubMed ID: 22772487
[TBL] [Abstract][Full Text] [Related]
42. The natural bile acid surfactant sodium taurocholate (NaTC) as a coformer in coamorphous systems: Enhanced physical stability and dissolution behavior of coamorphous drug-NaTc systems.
Gniado K; MacFhionnghaile P; McArdle P; Erxleben A
Int J Pharm; 2018 Jan; 535(1-2):132-139. PubMed ID: 29107615
[TBL] [Abstract][Full Text] [Related]
43. Stable amorphous binary systems of glipizide and atorvastatin powders with enhanced dissolution profiles: formulation and characterization.
Renuka ; Singh SK; Gulati M; Narang R
Pharm Dev Technol; 2017 Feb; 22(1):13-25. PubMed ID: 26708555
[TBL] [Abstract][Full Text] [Related]
44. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
Ojarinta R; Saarinen J; Strachan CJ; Korhonen O; Laitinen R
Eur J Pharm Biopharm; 2018 Nov; 132():112-126. PubMed ID: 30248394
[TBL] [Abstract][Full Text] [Related]
45. Compression-induced crystallization of amorphous indomethacin in tablets: characterization of spatial heterogeneity by two-dimensional X-ray diffractometry.
Thakral NK; Mohapatra S; Stephenson GA; Suryanarayanan R
Mol Pharm; 2015 Jan; 12(1):253-63. PubMed ID: 25438193
[TBL] [Abstract][Full Text] [Related]
46. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
[TBL] [Abstract][Full Text] [Related]
47. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
Newman A; Zografi G
Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
[TBL] [Abstract][Full Text] [Related]
48. Designing a Novel Coamorphous Salt Formulation of Telmisartan with Amlodipine to Enhance Permeability and Oral Absorption.
Hatanaka Y; Uchiyama H; Kaneko S; Ueda K; Higashi K; Moribe K; Furukawa S; Takase M; Yamanaka S; Kadota K; Tozuka Y
Mol Pharm; 2023 Aug; 20(8):4071-4085. PubMed ID: 37498232
[TBL] [Abstract][Full Text] [Related]
49. Use of glancing angle X-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets.
Debnath S; Predecki P; Suryanarayanan R
Pharm Res; 2004 Jan; 21(1):149-59. PubMed ID: 14984270
[TBL] [Abstract][Full Text] [Related]
50. Dual-drug amorphous formulation of gliclazide.
Aljohani M; McArdle P; Erxleben A
Drug Dev Ind Pharm; 2021 Feb; 47(2):302-307. PubMed ID: 33492999
[TBL] [Abstract][Full Text] [Related]
51. Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.
Shah A; Serajuddin AT
Int J Pharm; 2015 Apr; 484(1-2):172-80. PubMed ID: 25724137
[TBL] [Abstract][Full Text] [Related]
52. The Binary System of Ibuprofen-Nicotinamide Under Nanoscale Confinement: From Cocrystal to Coamorphous State.
Bi Y; Xiao D; Ren S; Bi S; Wang J; Li F
J Pharm Sci; 2017 Oct; 106(10):3150-3155. PubMed ID: 28625724
[TBL] [Abstract][Full Text] [Related]
53. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K
Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654
[TBL] [Abstract][Full Text] [Related]
54. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
[TBL] [Abstract][Full Text] [Related]
55. Coformer-Dependent Physical Stability in a Series of Naringenin-Based Coamorphous Materials with Caffeine, Theophylline, and Theobromine.
Jadhav S; Bahl D; Stevens LL
Pharm Res; 2023 Dec; 40(12):2847-2858. PubMed ID: 37505378
[TBL] [Abstract][Full Text] [Related]
56. Molecular Dynamics and Physical Stability of Coamorphous Ezetimib and Indapamide Mixtures.
Knapik J; Wojnarowska Z; Grzybowska K; Jurkiewicz K; Tajber L; Paluch M
Mol Pharm; 2015 Oct; 12(10):3610-9. PubMed ID: 26301858
[TBL] [Abstract][Full Text] [Related]
57. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
58. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
[No Abstract] [Full Text] [Related]
59. Co-grinding Effect on Crystalline Zaltoprofen with β-cyclodextrin/Cucurbit[7]uril in Tablet Formulation.
Li S; Lin X; Xu K; He J; Yang H; Li H
Sci Rep; 2017 Apr; 7():45984. PubMed ID: 28368030
[TBL] [Abstract][Full Text] [Related]
60. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
